Resveratrol: an effective pharmacological agent to prevent inflammation-induced atrial fibrillation?

Henry Sutanto, Dobromir Dobrev, Jordi Heijman*

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

Original languageEnglish
Pages (from-to)1163-1167
Number of pages5
JournalNaunyn-Schmiedebergs Archives of Pharmacology
Volume391
Issue number11
DOIs
Publication statusPublished - Nov 2018

Keywords

  • RISK
  • PATHOPHYSIOLOGY
  • EPIDEMIOLOGY
  • MANAGEMENT
  • MECHANISMS
  • INSIGHTS
  • DISEASE
  • HEART

Cite this